Related Experiment Video

Updated: Aug 15, 2026

Identification of Virulence Markers of Mycobacterium abscessus for Intracellular Replication in Phagocytes
08:34

Identification of Virulence Markers of Mycobacterium abscessus for Intracellular Replication in Phagocytes

Published on: September 27, 2018

Mycobacterium-avium complex

D S Rubin1, J J Rahal

  • 1New York Hospital Medical Center of Queens, Flushing.

Infectious Disease Clinics of North America
|June 1, 1994
PubMed

Insights

Disseminated MAC (mycobacterium avium complex) is a significant threat for AIDS patients with low CD4 counts. Prophylaxis and targeted multi-drug therapy are crucial for managing this opportunistic infection.

Area of Science:

  • Infectious Diseases
  • Immunology
  • HIV/AIDS Research

Background:

  • Mycobacterium avium complex (MAC) is a common opportunistic infection in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • Prolonged immunodeficiency in advanced HIV infection leads to increased susceptibility to disseminated MAC (DMAC).

Purpose of the Study:

  • To highlight the growing clinical importance of MAC as an opportunistic pathogen in the context of advanced HIV.
  • To emphasize the role of CD4 T-cell counts in DMAC risk and the need for prophylaxis.
  • To outline current therapeutic strategies for DMAC in immunocompromised patients.

Main Methods:

  • Literature review and synthesis of clinical data regarding MAC in AIDS patients.
  • Analysis of risk factors, particularly CD4 T-cell counts.
  • Evaluation of therapeutic regimens for DMAC.

Main Results:

  • Disseminated MAC is prevalent in a significant proportion of AIDS patients.
  • A CD4 count below 100 cells/mm³ is the primary risk factor for DMAC.
  • Prophylaxis can substantially decrease DMAC incidence in advanced HIV.
  • Multi-drug regimens, including macrolides, are indicated for DMAC treatment.

Conclusions:

  • DMAC is an emerging clinical challenge in the growing population of long-term survivors with HIV.
  • Effective prophylaxis and judicious multi-drug therapy are essential for managing DMAC.
  • Minimizing drug toxicity and interactions is critical when treating debilitated patients with DMAC.

More Related Videos

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

Identification of Mycobacterium Species by DNA Microarray Chip Method06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...